000028 国药一致
已收盘 11-19 15:00:00
资讯
新帖
简况
11月12日国药一致涨7.63%,东方红启恒三年持有混合A基金重仓该股
证券之星 · 11-12
11月12日国药一致涨7.63%,东方红启恒三年持有混合A基金重仓该股
异动快报:国药一致(000028)11月12日10点16分触及涨停板
证券之星 · 11-12
异动快报:国药一致(000028)11月12日10点16分触及涨停板
华源证券:给予国药一致买入评级
证券之星 · 10-30
华源证券:给予国药一致买入评级
国药一致(000028)2024年三季报简析:净利润减10.43%,盈利能力上升
证券之星 · 10-30
国药一致(000028)2024年三季报简析:净利润减10.43%,盈利能力上升
国药一致(000028.SZ)发布前三季度业绩,净利润10.66亿元,同比下降10.43%
智通财经 · 10-28
国药一致(000028.SZ)发布前三季度业绩,净利润10.66亿元,同比下降10.43%
国药一致最新公告:前三季度净利润同比下降10.43%
证券之星 · 10-28
国药一致最新公告:前三季度净利润同比下降10.43%
国药控股:国药一致前三季度归母净利润为约10.66亿元 同比下降10.43%
新浪港股 · 10-23
国药控股:国药一致前三季度归母净利润为约10.66亿元 同比下降10.43%
国药一致最新公告:2024年前三季度净利润同比下降10.43%
证券之星 · 10-22
国药一致最新公告:2024年前三季度净利润同比下降10.43%
国药(01099.HK)附属国药一致首九月赚10.66亿人民币 倒退10.4%
阿斯达克财经 · 10-22
国药(01099.HK)附属国药一致首九月赚10.66亿人民币 倒退10.4%
国药控股(01099):国药一致(000028.SZ)前三季度归母净利为约10.66亿元 同比下降10.43%
智通财经 · 10-22
国药控股(01099):国药一致(000028.SZ)前三季度归母净利为约10.66亿元 同比下降10.43%
国药一致发布2024年前三季度业绩快报 归属净利润盈利10.655亿元
证券之星 · 10-22
国药一致发布2024年前三季度业绩快报 归属净利润盈利10.655亿元
国药一致(000028.SZ):前三季度净利润10.66亿元 同比减少10.43%
智通财经 · 10-22
国药一致(000028.SZ):前三季度净利润10.66亿元 同比减少10.43%
国药一致业绩快报:前三季度净利润下降10.43%
美港电讯 · 10-22
国药一致业绩快报:前三季度净利润下降10.43%
国药一致(000028)10月8日主力资金净卖出4447.43万元
证券之星 · 10-09
国药一致(000028)10月8日主力资金净卖出4447.43万元
国药控股董事会秘书、国药一致董事长吴壹建一行赴新疆国大调研
国药一致官微 · 09-18
国药控股董事会秘书、国药一致董事长吴壹建一行赴新疆国大调研
国药一致:专业药房主要是面对慢病、重病患者,除了接待患者到店买药,门店还提供送药上门服务
证券之星 · 09-09
国药一致:专业药房主要是面对慢病、重病患者,除了接待患者到店买药,门店还提供送药上门服务
华源证券:给予国药一致买入评级
证券之星 · 09-05
华源证券:给予国药一致买入评级
华源证券给予国药一致买入评级,整体业绩承压,分销业务相对稳健
每日经济新闻 · 09-05
华源证券给予国药一致买入评级,整体业绩承压,分销业务相对稳健
【机构调研记录】长安基金调研国药一致、翔宇医疗
证券之星 · 09-04
【机构调研记录】长安基金调研国药一致、翔宇医疗
【机构调研记录】金元顺安基金调研蓝帆医疗、国药一致等7只个股(附名单)
证券之星 · 09-04
【机构调研记录】金元顺安基金调研蓝帆医疗、国药一致等7只个股(附名单)
加载更多
公司概况
公司名称:
国药集团一致药业股份有限公司
所属行业:
批发业
上市日期:
1993-08-09
主营业务:
国药集团一致药业股份有限公司是集制药工业、医药批发、零售连锁为一体的医药上市公司,控股股东为国药控股有限公司。主要经营医药企业受托管理、资产重组,医药实业投资项目的咨询服务,举办医疗器械的展览展销,中药材、中成药、中药饮片、化学原料药、化学药制剂、抗生素、生化药品、生物制品的批发(经营期限以许可证为准)。公司坚持走研发、制药、分销、物流、零售一体化发展道路,旗下拥有致君制药、万乐公司、一致药店等公司,其中一致药店为国内最大规模的连锁药店之一,公司属下国大药房是全国销售规模领先的医药零售企业,是国内少数拥有全国性直营药品零售网络的企业之一。
发行价格:
3.50
{"stockData":{"symbol":"000028","market":"SZ","secType":"STK","nameCN":"国药一致","latestPrice":31.15,"timestamp":1731999837000,"preClose":31.65,"halted":0,"volume":7893737,"delay":0,"floatShares":478000000,"shares":557000000,"eps":2.6505,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.5,"latestTime":"11-19 15:00:00","open":31.59,"high":31.85,"low":30.41,"amount":245000000,"amplitude":0.0455,"askPrice":31.16,"askSize":61,"bidPrice":31.15,"bidSize":206,"shortable":0,"etf":0,"ttmEps":2.6505,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732066200000},"adr":0,"adjPreClose":31.65,"symbolType":"stock","openAndCloseTimeList":[[1731979800000,1731987000000],[1731992400000,1731999600000]],"highLimit":34.82,"lowLimit":28.49,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":556565077,"pbRate":0.97,"roa":"--","roe":"5.99%","epsLYR":2.87,"committee":0.695437,"marketValue":17337000000,"floatMarketCap":14891000000,"peRate":11.752499,"changeRate":-0.0158,"turnoverRate":0.0165,"status":1},"requestUrl":"/m/hq/s/000028","defaultTab":"news","newsList":[{"id":"2482972101","title":"11月12日国药一致涨7.63%,东方红启恒三年持有混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482972101","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482972101?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:07","pubTimestamp":1731398860,"startTime":"0","endTime":"0","summary":"证券之星消息,11月12日国药一致涨7.63%,收盘报32.18元,换手率5.09%,成交量24.34万手,成交额7.82亿元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为东方红启恒三年持有混合A。东方红启恒三年持有混合A目前规模为7.04亿元,最新净值9.4081,较上一交易日下跌1.0%,近一年上涨14.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200025344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","000028","BK0250","BK0082","BK0175","BK0196","BK0010","BK0188","BK0028"],"gpt_icon":0},{"id":"2482713957","title":"异动快报:国药一致(000028)11月12日10点16分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2482713957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482713957?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:20","pubTimestamp":1731378036,"startTime":"0","endTime":"0","summary":"证券之星11月12日盘中消息,10点16分国药一致触及涨停板。目前价格32.89,上涨10.0%。11月11日的资金流向数据方面,主力资金净流出48.17万元,占总成交额0.32%,游资资金净流出365.36万元,占总成交额2.4%,散户资金净流入413.52万元,占总成交额2.72%。近5日资金流向一览见下表:国药一致主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200011290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000028","BK0028","BK0175","BK0010","BK0196","BK0185","BK0082","BK0188"],"gpt_icon":0},{"id":"2479214124","title":"华源证券:给予国药一致买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479214124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479214124?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:57","pubTimestamp":1730260653,"startTime":"0","endTime":"0","summary":"华源证券股份有限公司刘闯近期对国药一致进行研究并发布了研究报告《Q3零售板块环比显著改善,恢复盈利可期》,本报告对国药一致给出买入评级,当前股价为27.8元。 国药一致 投资要点: 事件:国药一致公布2024年三季度业绩。最新盈利预测明细如下:该股最近90天内共有5家机构给出评级,买入评级5家;过去90天内机构目标均价为32.43。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000019732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","000028"],"gpt_icon":0},{"id":"2479269193","title":"国药一致(000028)2024年三季报简析:净利润减10.43%,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2479269193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479269193?lang=zh_cn&edition=full","pubTime":"2024-10-30 06:19","pubTimestamp":1730240365,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期国药一致发布2024年三季报。截至本报告期末,公司营业总收入564.66亿元,同比下降0.21%,归母净利润10.66亿元,同比下降10.43%。按单季度数据看,第三季度营业总收入186.8亿元,同比上升2.65%,第三季度归母净利润3.22亿元,同比下降10.39%。本报告期国药一致盈利能力上升,毛利率同比增幅1.82%,净利率同比增幅43.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000006000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"gpt_icon":0},{"id":"2478104810","title":"国药一致(000028.SZ)发布前三季度业绩,净利润10.66亿元,同比下降10.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478104810","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478104810?lang=zh_cn&edition=full","pubTime":"2024-10-28 20:01","pubTimestamp":1730116860,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药一致(000028.SZ)发布2024年三季度报告,前三季度,公司实现营业收入564.66亿元,同比下降0.21%。归属于上市公司股东的净利润10.66亿元,同比下降10.43%。归属于上市公司股东的扣除非经常性损益的净利润10.24亿元,同比下降10.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1201602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000028"],"gpt_icon":0},{"id":"2478210349","title":"国药一致最新公告:前三季度净利润同比下降10.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478210349","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478210349?lang=zh_cn&edition=full","pubTime":"2024-10-28 18:50","pubTimestamp":1730112602,"startTime":"0","endTime":"0","summary":"国药一致发布2024年第三季度报告,前三季度实现营业收入564.66亿元,同比下降0.21%;归属于上市公司股东的净利润10.66亿元,同比下降10.43%。第三季度实现营业收入186.80亿元,同比增长2.65%;归属于上市公司股东的净利润3.22亿元,同比下降10.39%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800026150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"gpt_icon":0},{"id":"2477323319","title":"国药控股:国药一致前三季度归母净利润为约10.66亿元 同比下降10.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477323319","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477323319?lang=zh_cn&edition=full","pubTime":"2024-10-23 08:04","pubTimestamp":1729641840,"startTime":"0","endTime":"0","summary":" 国药控股公布国药一致2024年度前三季度业绩快报,实现营业收入564.66亿元,同比下降0.21%;归属于上市公司股东的净利润10.66亿元,同比下降10.43%,相应的基本每股收益同比下降10.75%,加权平均净资产收益率同比下降1.19个百分点。2024年第三季度,实现营业收入186.80亿元,同比增长 2.65%;归属上市公司股东的净利润3.22亿元,同比下降10.39%。 2024年1-9月,分销板块实现营业收入408.36亿元,同比增长 3.20%;实现净利润7.81亿元,同比下降0.91%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-23/doc-inctnueh1019517.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-23/doc-inctnueh1019517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000028","01099"],"gpt_icon":0},{"id":"2477353704","title":"国药一致最新公告:2024年前三季度净利润同比下降10.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477353704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477353704?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:30","pubTimestamp":1729607454,"startTime":"0","endTime":"0","summary":"国药一致发布2024年前三季度业绩快报,公司实现营业收入564.66亿元,同比下降0.21%;归属于上市公司股东的净利润10.66亿元,同比下降10.43%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200037107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"gpt_icon":0},{"id":"2477358089","title":"国药(01099.HK)附属国药一致首九月赚10.66亿人民币 倒退10.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477358089","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477358089?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:16","pubTimestamp":1729606560,"startTime":"0","endTime":"0","summary":"国药控股(01099.HK) 公布,附属国药一致(000028.SZ) 首九个月业绩,实现营业总收入564.66亿人民币(下同),按年微降0.2%。归属股东净利润10.66亿元,倒退10.4%,每股收益1.91元。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-22 16:25。) (A股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/08/23中期业绩无派息2024/04/26第一季业绩无派息2024/03/22末期业绩普通股息:人民币 0.87 (相当于港元 0.956)2023/10/27第三季业绩无派息AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180321104207082_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180321104207082_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1390152/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","BK0196","LU1115378108.SGD","BK0082","BK0185","BK0028","01099","BK0188","BK0250","BK1500","LU0640798160.USD","BK0175","000028","BK1197","BK0010"],"gpt_icon":0},{"id":"2477229331","title":"国药控股(01099):国药一致(000028.SZ)前三季度归母净利为约10.66亿元 同比下降10.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477229331","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477229331?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:07","pubTimestamp":1729602450,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药控股 公布国药一致2024年度前三季度业绩快报,实现营业收入564.66亿元,同比下降0.21%;归属于上市公司股东的净利润10.66亿元,同比下降10.43%,相应的基本每股收益同比下降10.75%,加权平均净资产收益率同比下降1.19个百分点。2024年第三季度,实现营业收入186.80亿元,同比增长 2.65%;归属上市公司股东的净利润3.22亿元,同比下降10.39%。零售板块实现营业收入163.97亿元,同比下降7.47%;实现净利润-0.39亿元,同比下降110.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1197682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","000028","BK0188","BK0028","BK0010","BK0175","LU0640798160.USD","01099","BK1197","BK1500","LU1115378108.SGD","BK0082","BK0196","BK0185","BK1515"],"gpt_icon":0},{"id":"2477380470","title":"国药一致发布2024年前三季度业绩快报 归属净利润盈利10.655亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477380470","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477380470?lang=zh_cn&edition=full","pubTime":"2024-10-22 19:40","pubTimestamp":1729597216,"startTime":"0","endTime":"0","summary":"证券之星消息,国药一致近日即将发布2024年三季报,根据10月22日发布的业绩快报,归属净利润盈利10.655亿元,同比减少10.43%。2024年第三季度,公司实现营业收入186.80亿元,同比增长2.65%;归属上市公司股东的净利润3.22亿元,同比下降10.39%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200032044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000028"],"gpt_icon":0},{"id":"2477976380","title":"国药一致(000028.SZ):前三季度净利润10.66亿元 同比减少10.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477976380","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477976380?lang=zh_cn&edition=full","pubTime":"2024-10-22 19:36","pubTimestamp":1729597011,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国药一致(000028.SZ)发布2024年度前三季度业绩快报,报告期内公司实现营业收入564.66亿元,同比减少0.21%;归属于上市公司股东的净利润10.66亿元,同比减少10.43%;归属于上市公司股东的扣除非经常性损益的净利润10.24亿元,同比减少10.39%;基本每股收益1.91元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1197626.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000028"],"gpt_icon":0},{"id":"2477015387","title":"国药一致业绩快报:前三季度净利润下降10.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477015387","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477015387?lang=zh_cn&edition=full","pubTime":"2024-10-22 19:30","pubTimestamp":1729596622,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0185","BK0188","BK0250","BK0028","BK0175","BK0196","000028","BK0082","BK0010"],"gpt_icon":0},{"id":"2474237207","title":"国药一致(000028)10月8日主力资金净卖出4447.43万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474237207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474237207?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:25","pubTimestamp":1728437116,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月8日收盘,国药一致报收于31.97元,上涨1.07%,换手率3.95%,成交量18.89万手,成交额6.14亿元。10月8日的资金流向数据方面,主力资金净流出4447.43万元,占总成交额7.25%,游资资金净流出1090.28万元,占总成交额1.78%,散户资金净流入5537.71万元,占总成交额9.03%。融券方面,融券卖出7900.0股,融券偿还400.0股,融券余量5.49万股,融券余额175.43万元。国药一致主营业务:医药分销和医药零售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900005807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000028","BK0028","BK0175","BK0010","BK0196","BK0185","BK0082","BK0188"],"gpt_icon":0},{"id":"2468573309","title":"国药控股董事会秘书、国药一致董事长吴壹建一行赴新疆国大调研","url":"https://stock-news.laohu8.com/highlight/detail?id=2468573309","media":"国药一致官微","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468573309?lang=zh_cn&edition=full","pubTime":"2024-09-18 18:24","pubTimestamp":1726655084,"startTime":"0","endTime":"0","summary":"9月11日至12日,国药控股董事会秘书、国药一致董事长吴壹建,国药一致党委副书记(主持党委工作)、副总经理李进雄,国药控股零售诊疗事业部副总经理陈剑刚一行前往新疆国大进行实地调研。 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20240918/c661767953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0196","BK0082","BK0188","BK0028","BK0250","000028","BK0175","BK0010","BK0185"],"gpt_icon":0},{"id":"2466163608","title":"国药一致:专业药房主要是面对慢病、重病患者,除了接待患者到店买药,门店还提供送药上门服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2466163608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466163608?lang=zh_cn&edition=full","pubTime":"2024-09-09 19:01","pubTimestamp":1725879681,"startTime":"0","endTime":"0","summary":"证券之星消息,国药一致09月09日在投资者关系平台上答复投资者关心的问题。专业药房主要是面对慢病、重病患者,除了接待患者到店买药,门店还提供送药上门服务。国大药房目前在珠海暂未开店。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090900026564.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","000028","BK0028","BK0010","BK0250","BK0185","BK0175","BK0082"],"gpt_icon":0},{"id":"2465595869","title":"华源证券:给予国药一致买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2465595869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465595869?lang=zh_cn&edition=full","pubTime":"2024-09-05 11:55","pubTimestamp":1725508553,"startTime":"0","endTime":"0","summary":"华源证券股份有限公司刘闯近期对国药一致进行研究并发布了研究报告《整体业绩承压,分销业务相对稳健》,本报告对国药一致给出买入评级,当前股价为25.22元。公司为全国领先的分销及零售平台,分销业务通过深耕优势区域有望保持稳健增长,零售业务盈利能力改善潜力大,维持公司“买入”评级。最新盈利预测明细如下:该股最近90天内共有2家机构给出评级,买入评级2家;过去90天内机构目标均价为33.35。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090500016259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","000028"],"gpt_icon":0},{"id":"2465590561","title":"华源证券给予国药一致买入评级,整体业绩承压,分销业务相对稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=2465590561","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465590561?lang=zh_cn&edition=full","pubTime":"2024-09-05 10:10","pubTimestamp":1725502200,"startTime":"0","endTime":"0","summary":"华源证券09月05日发布研报称,给予国药一致(000028.SZ,最新价:25.24元)买入评级。评级理由主要包括:1)分销业务收入相对稳健,利润略有下滑;2)零售业务承压,开店节奏稳健;3)费用控制良好,毛利率有所下降。风险提示:行业政策风险;国大药房利润率改善不及预期;集采降价超预期。(文章来源:每日经济新闻)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-05/doc-incnahzr5484739.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-05/doc-incnahzr5484739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000028","161027"],"gpt_icon":0},{"id":"2464364858","title":"【机构调研记录】长安基金调研国药一致、翔宇医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2464364858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464364858?lang=zh_cn&edition=full","pubTime":"2024-09-04 08:03","pubTimestamp":1725408200,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的公募基金产品为长安泓源纯债债券A,最新单位净值为1.04,近一年增长5.42%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090400007589.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688626","BK0175","BK0010","BK0028","BK0185","BK0196","BK0250","BK0251","000028","BK0082","BK0188"],"gpt_icon":0},{"id":"2464096361","title":"【机构调研记录】金元顺安基金调研蓝帆医疗、国药一致等7只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2464096361","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464096361?lang=zh_cn&edition=full","pubTime":"2024-09-04 08:03","pubTimestamp":1725408188,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及9月3日披露的机构调研信息,金元顺安基金近期对7家上市公司进行了调研,相关名单如下:1)蓝帆医疗 个股亮点:蓝帆转债于2020-06-19上市;公司有专业的医疗防护手套及口罩。金元顺安基金成立于2006年,截至目前,资产管理规模349.94亿元,排名97/206;资产管理规模232.64亿元,排名100/206;管理公募基金数34只,排名119/206;旗下公募基金经理14人,排名90/206。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090400007570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0250","BK0077","BK0251","BK0185","BK0175","BK0188","000028","BK0082","BK0028","BK0196","BK0010","002382"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1993-08-09","address":"广东省深圳市福田区园岭街道八卦四路15号一致药业大厦","stockEarnings":[{"period":"1week","weight":0.0585},{"period":"1month","weight":0.1231},{"period":"3month","weight":0.1727},{"period":"6month","weight":-0.1349},{"period":"1year","weight":0.0514},{"period":"ytd","weight":0.1149}],"companyName":"国药集团一致药业股份有限公司","boardCode":"AI0051","perCapita":"--","boardName":"批发业","registeredCapital":"55656万元","compareEarnings":[{"period":"1week","weight":-0.0421},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.1595},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.0882},{"period":"ytd","weight":0.1173}],"survey":" 国药集团一致药业股份有限公司是集制药工业、医药批发、零售连锁为一体的医药上市公司,控股股东为国药控股有限公司。主要经营医药企业受托管理、资产重组,医药实业投资项目的咨询服务,举办医疗器械的展览展销,中药材、中成药、中药饮片、化学原料药、化学药制剂、抗生素、生化药品、生物制品的批发(经营期限以许可证为准)。公司坚持走研发、制药、分销、物流、零售一体化发展道路,旗下拥有致君制药、万乐公司、一致药店等公司,其中一致药店为国内最大规模的连锁药店之一,公司属下国大药房是全国销售规模领先的医药零售企业,是国内少数拥有全国性直营药品零售网络的企业之一。","serverTime":1732023949490,"listedPrice":3.5,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药一致,000028,国药一致股票,国药一致股票老虎,国药一致股票老虎国际,国药一致行情,国药一致股票行情,国药一致股价,国药一致股市,国药一致股票价格,国药一致股票交易,国药一致股票购买,国药一致股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}